Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Yang, Xiangliang  [Clear All Filters]
2023
Xu C, Li S, Chen J, Wang H, Li Z, Deng Q, Li J, Wang X, Xiong Y, Zhang Z, et al. Doxorubicin and erastin co-loaded hydroxyethyl starch-polycaprolactone nanoparticles for synergistic cancer therapy. J Control Release. 2023.
Liu H, Xu S, Yong T, Wei Z, Bie N, Zhang X, Li X, Li J, Li S, Wang S, et al. Hydrophobicity-Adaptive Polymers Trigger Fission of Tumor Cell-Derived Microparticles for Enhanced Anticancer Drug Delivery. Adv Mater. 2023:e2211980.
Xiao C, Li J, Wang X, Li S, Xu C, Zhang Z, Hua A, Ding Z-Y, Zhang B-X, Yang X, et al. Hydroxyethyl starch stabilized copper-diethyldithiocarbamate nanocrystals for cancer therapy. J Control Release. 2023.
Xiong Y, Yong Z, Xu C, Deng Q, Wang Q, Li S, Wang C, Zhang Z, Yang X, Li Z. Hyperbaric Oxygen Activates Enzyme-Driven Cascade Reactions for Cooperative Cancer Therapy and Cancer Stem Cells Elimination. Adv Sci (Weinh). 2023:e2301278.
Wang Q, Li S, Xu C, Hua A, Wang C, Xiong Y, Deng Q, Chen X, Yang T, Wan J, et al. A novel lonidamine derivative targeting mitochondria to eliminate cancer stem cells by blocking glutamine metabolism. Pharmacol Res. 2023:106740.
Wang Q, Yang T, Li S, Xu C, Wang C, Xiong Y, Wang X, Wan J, Yang X, Li Z. Unimolecular Self-Assembled Hemicyanine-Oleic Acid Conjugate Acts as a Novel Succinate Dehydrogenase Inhibitor to Amplify Photodynamic Therapy and Eliminate Cancer Stem Cells. Research (Wash D C). 2023;6:0223.
2022
Wang C, Wang Q, Wang H, Li Z, Chen J, Zhang Z, Zeng H, Yu X, Yang X, Yang X, et al. Hydroxyethyl starch-folic acid conjugates stabilized theranostic nanoparticles for cancer therapy. J Control Release. 2022.